July 21, 2026 12:33 PM GMT CSL Ltd M Asia Pacific Insight Back to basics What's Changed | CSL Ltd (CSL.AX) | From | To | | --- | --- | --- | | Price Target | A$174.00 | A$163.00 | We remain OW following a review of the outlook for Ig and albumin, with medium-term upside from key pipeline candidates. Key Takeaways Key takeaways from our analysis: (1) Industry immunoglobulin (Ig) revenue rose ~7.5% in 2025, with lower growth for CSL implying market share loss. Over the medium to longer-term, we continue to se ...